Internal Medicine, Nephrology · Porterville, CA
NPI
1659303980
Since 2006
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
557 W Morton Ave, Suite A
Porterville, CA, 93257
Phone (559) 784-4925
Groups this clinician bills Medicare through
Medicare paid, 2024
$494K
6,491 services
Medicare patients, 2024
876
Average age 75
Drug cost, 2024
$3.2M
27,132 prescriptions
Company payments, 2025
$977
From 19 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Nirupama Vemuri was code 99214 (office e&m - established), 1,001 times for 452 patients. In total Nirupama Vemuri billed 6,491 services in 57 codes, and Medicare paid $494K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,001 | 452 | $82.78 | $83K |
| 99213 Office E&M - Established | Office | 876 | 471 | $45.79 | $40K |
| 99233 Hospital E&M - Subsequent | Facility | 580 | 170 | $88.35 | $51K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 576 | 352 | $11.91 | $6,861 |
| 99232 Hospital E&M - Subsequent | Facility | 463 | 154 | $58.09 | $27K |
| 90960 ESRD Related Services (not dialysis) | Facility | 451 | 57 | $265.27 | $120K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 355 | 355 | $127.40 | $45K |
| 96372 Injection Administration | Office | 353 | 102 | $9.79 | $3,456 |
| J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 253 | 57 | $0.88 | $222 |
| 99222 Hospital E&M - Initial | Facility | 218 | 165 | $92.55 | $20K |
| G0008 Administration of influenza virus vaccine | Office | 187 | 180 | $32.91 | $6,154 |
| 90661 Vaccine Product | Office | 177 | 177 | $35.91 | $6,355 |
| 99307 SNF E&M | Office | 117 | 22 | $28.03 | $3,280 |
| 90961 ESRD Related Services (not dialysis) | Facility | 107 | 53 | $221.77 | $24K |
| 99238 Hospital Discharge Management | Facility | 67 | 54 | $61.73 | $4,136 |
By year: 2022 $523K for 6,220 services; 2023 $528K for 6,401 services; 2024 $494K for 6,491 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 17 | 15 | $3.41 | $57.97 |
Medicare prescription drug claims, 2024
In 2024, the drug Nirupama Vemuri prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,709 prescriptions and refills. In total Nirupama Vemuri wrote 27,132 Medicare prescriptions that cost $3.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,709 | 4,295 | 411 | $13K |
| Levothyroxine Sodium Generic | 1,223 | 2,880 | 241 | $12K |
| Amlodipine Besylate Generic | 674 | 1,868 | 195 | $3,877 |
| Furosemide Generic | 630 | 1,169 | 150 | $3,121 |
| Gabapentin Generic | 606 | 906 | 117 | $4,113 |
| Pantoprazole Sodium Generic | 567 | 1,032 | 120 | $4,577 |
| Lisinopril Generic | 549 | 1,329 | 132 | $2,419 |
| Metoprolol Succinate Generic | 526 | 1,350 | 149 | $7,385 |
| Metformin Hcl Generic | 520 | 1,317 | 132 | $3,227 |
| Sertraline Hcl Generic | 513 | 822 | 96 | $2,984 |
| Ozempic Semaglutide | 445 | 609 | 85 | $561K |
| Allopurinol Generic | 441 | 1,009 | 95 | $3,419 |
| Calcitriol Generic | 437 | 976 | 113 | $8,495 |
| Losartan Potassium Generic | 388 | 1,037 | 103 | $3,312 |
| Tamsulosin Hcl Generic | 368 | 908 | 89 | $4,024 |
Brand drugs: 4,151 claims; generic drugs: 22,780 claims; opioid claims: 212.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Nirupama Vemuri $977 ($977 in general payments such as food, travel and fees) from 19 companies. The largest payer was Amgen Inc. with $221.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 5 | $221 |
| Lilly USA, LLC LLY | 2 | $130 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $87.78 |
| Calliditas Therapeutics US Inc. | 4 | $71.26 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 3 | $58.36 |
| Ardelyx, Inc. ARDX | 3 | $56.26 |
| Phathom Pharmaceuticals, Inc. PHAT | 3 | $49.02 |
| Travere Therapeutics, Inc. TVTX | 3 | $48.1 |
| Abbott Laboratories ABT | 2 | $39.53 |
| GlaxoSmithKline, LLC. GSK | 2 | $28.85 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.